These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 8949735)

  • 1. Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note.
    Blum K; Oscar-Berman M; Femino J; Waite RL; Benya L; Giordano J; Borsten J; Downs WB; Braverman ER; Loehmann R; Dushaj K; Han D; Simpatico T; Hauser M; Barh D; McLaughlin T
    J Addict Res Ther; 2013 Apr; 4(2):. PubMed ID: 24273683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid dependence.
    Praveen KT; Law F; O'Shea J; Melichar J
    Am Fam Physician; 2012 Sep; 86(6):565-6. PubMed ID: 23062049
    [No Abstract]   [Full Text] [Related]  

  • 3. Transferring methadone-stabilized pregnant patients to buprenorphine using an immediate release morphine transition: an open-label exploratory study.
    Jones HE; Suess P; Jasinski DR; Johnson RE
    Am J Addict; 2006; 15(1):61-70. PubMed ID: 16449094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification.
    Sobel BF; Sigmon SC; Walsh SL; Johnson RE; Liebson IA; Nuwayser ES; Kerrigan JH; Bigelow GE
    Drug Alcohol Depend; 2004 Jan; 73(1):11-22. PubMed ID: 14687955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double successful buprenorphine/naloxone induction to facilitate cardiac transplantation in an iatrogenically opiate-dependent patient.
    Rodgman C; Pletsch G
    J Addict Med; 2012 Jun; 6(2):177-8. PubMed ID: 22456493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine.
    Lopatko OV; White JM; Huber A; Ling W
    Drug Alcohol Depend; 2003 Apr; 69(3):317-22. PubMed ID: 12633918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Withdrawal syndrome in 2 drug addicts after intravenous injection of buprenorphine?].
    Gourarier L; Lowenstein W; Gisselbrecht M; Chauveau JM; Haas C; Durand H
    Presse Med; 1996 Sep; 25(27):1239-40. PubMed ID: 8949735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methadone and buprenorphine--attractive on the street and outside treatment programs].
    Johnson B
    Lakartidningen; 2011 Oct 9-15; 108(45):2309-11. PubMed ID: 22242248
    [No Abstract]   [Full Text] [Related]  

  • 9. The opiate-dependent patient with endocarditis: addressing pain and substance abuse withdrawal.
    Broyles LM; Korniewicz DM
    AACN Clin Issues; 2002 Aug; 13(3):431-51. PubMed ID: 12151996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The major medical sequelae of opioid addiction.
    Cushman P
    Drug Alcohol Depend; 1980 Apr; 5(4):239-54. PubMed ID: 6245846
    [No Abstract]   [Full Text] [Related]  

  • 11. Acupuncture-related techniques for the treatment of opiate addiction: a case of translational medicine.
    Han J; Cui C; Wu L
    Front Med; 2011 Jun; 5(2):141-50. PubMed ID: 21695618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of opiates on the lung.
    Lao PN
    Clin Rev Allergy Immunol; 1997; 15(3):291-305. PubMed ID: 9358989
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.